Pharmacokinetics of LCQ908 in Patients With Hepatic Impairment

Status:
Completed

Trial end date:
2013-04-01

Target enrollment:

Participant gender:

This study will compare the pharmacokinetics of LCQ908 in subjects with varying degrees of hepatic impairment to healthy subjects.

Phase 1

Novartis Pharmaceuticals